meglumine antimoniate has been researched along with Hepatic Failure in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bóia, MN; Brustoloni, YM; Cunha, RV; Dorval, ME; Fernandes, TD; Oliveira, AL | 1 |
1 other study(ies) available for meglumine antimoniate and Hepatic Failure
| Article | Year |
|---|---|
Severe adverse reactions to meglumine antimoniate in the treatment of visceral leishmaniasis: a report of 13 cases in the southwestern region of Brazil.
Topics: Adolescent; Adult; Antiprotozoal Agents; Female; Heart; Humans; Leishmaniasis, Visceral; Liver Failure; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pancreatitis; Renal Insufficiency | 2009 |